Joseph F. Goldberg, MD

Dr Goldberg is a clinical professor of psychiatry at The Icahn School of Medicine at Mount Sinai in New York, NY and the immediate-past president of the American Society of Clinical Psychopharmacology.

Articles by Joseph F. Goldberg, MD

Bespoke Psychopharmacology for Bipolar Disorder: An Individualized Patient Approach

ByJoseph F. Goldberg, MD

September 10th 2020

The author discusses evidence-based treatment, highlighting clinical trials that support specific uses and patterns of efficacy.

The Psychopharmacology of Depression: Strategies, Formulations, and Future Implications

ByJoseph F. Goldberg, MD

July 31st 2018

Recent findings suggest that the magnitude of efficacy for most antidepressants compared with placebo may be more modest than previously thought.

Joseph F. Goldberg, MD

Articles by Joseph F. Goldberg, MD

Bespoke Psychopharmacology for Bipolar Disorder: An Individualized Patient Approach

The Psychopharmacology of Depression: Strategies, Formulations, and Future Implications

Trending on Psychiatric Times

Vol 43, Issue 9 - Interactive

FDA Hearing on Psychedelic Medicine Reveals a Field Divided on the Road to Approval

Insights on the New Adult ADHD Guidelines: A Conversation With the President of APSARD

New Adult ADHD Guidelines: What Resources Are Coming Soon

Phase 2 Failure: JNJ-5120/PIPE-307 for the Treatment of Major Depressive Disorder